ArticleAdvances in therapy2021

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US).

Jeffrey S Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.